tiprankstipranks
Halozyme Therapeutics (HALO)
NASDAQ:HALO
Holding HALO?
Track your performance easily

Halozyme (HALO) Technical Analysis

921 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Halozyme Therapeutics’s (HALO) Moving Averages Convergence Divergence (MACD) indicator is -2.00, suggesting Halozyme Therapeutics is a Buy.
Halozyme Therapeutics’s (HALO) 20-Day exponential moving average is 52.54, while Halozyme Therapeutics’s (HALO) share price is $45.7, making it a Sell.
Halozyme Therapeutics’s (HALO) 50-Day exponential moving average is 54.30, while Halozyme Therapeutics’s (HALO) share price is $45.7, making it a Sell.

Halozyme (HALO) Pivot Points

Nov 21, 2024, 05:50 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
40.56
41.60
43.21
44.25
45.86
46.90
48.51
Fibonacci
41.60
42.62
43.24
44.25
45.27
45.89
46.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (HALO) Moving Averages

Nov 21, 2024, 05:50 PM
Period
Simple
Exponential
MA5
46.55Sell
47.40Sell
MA10
53.27Sell
50.45Sell
MA20
53.42Sell
52.54Sell
MA50
55.15Sell
54.30Sell
MA100
56.04Sell
53.76Sell
MA200
49.17Sell
48.62Sell
Halozyme Therapeutics’s (HALO) 10-Day exponential moving average is 50.45, while Halozyme Therapeutics’s (HALO) share price is $45.7, making it a Sell.
Halozyme Therapeutics’s (HALO) 100-Day exponential moving average is 53.76, while Halozyme Therapeutics’s (HALO) share price is $45.7, making it a Sell.
Halozyme Therapeutics’s (HALO) stock price is $45.7 and Halozyme Therapeutics’s (HALO) 50-day simple moving average is 55.15, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $45.7 and Halozyme Therapeutics’s (HALO) 100-day simple moving average is 56.04, creating a Sell signal.
Halozyme Therapeutics’s (HALO) stock price is $45.7 and Halozyme Therapeutics’s (HALO) 200-day simple moving average is 49.17, creating a Sell signal.

Halozyme (HALO) Technical Indicators

Nov 21, 2024, 05:50 PM
Name
Value
Implied Action
RSI (14)
35.09
Neutral
STOCH (9,6)
11.78
Buy
STOCHRSI (14)
11.78
Buy
MACD (12,26)
-2.00
Buy
ADX (14)
32.06
Neutral
Williams %R
-81.36
Buy
CCI (14)
-100.73
Buy
ATR (14)
2.80
-
Ultimate Oscillator
29.24
Sell
ROC
-9.51
Sell
Halozyme Therapeutics’s (HALO) Relative Strength Index (RSI) is 35.09, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Trend Strength Indicator (ADX) is 32.06, creating a Neutral signal.
Halozyme Therapeutics’s (HALO) Commodity Channel Index (CCI) is -100.73, creating a Buy signal.
Halozyme Therapeutics’s (HALO) Price Rate of Change (ROC) is -9.51, creating a Sell signal.

FAQ

Is HALO a Buy, Hold, or Sell?
Based on HALO’s technical indicators, HALO is a Sell.
    What is HALO’s RSI (14)?
    HALO’s RSI (14) is 35.09, which suggests HALO is a Neutral.
      What is HALO’s MACD?
      HALO’s MACD is -2.00, which suggests HALO is a Buy.
        What is HALO’s 5-day moving average?
        HALO’s 5-day moving average is 46.55, which suggests HALO is a Sell.
          What is HALO’s 20-day moving average?
          HALO 20-day moving average is 53.42, which suggests HALO is a Sell.
            What is HALO’s 50-day moving average?
            HALO’s 50-day moving average is 55.15, which suggests HALO is a Sell.
              What is HALO’s 200-day moving average?
              HALO’s 200-day moving average is 49.17, which suggests HALO is a Sell.
                What is HALO’s Williams % R (14)?
                HALO’s Williams % R (14) is -81.36, which suggests HALO is a Buy.
                  What is HALO’s CCI (14)?
                  HALO’s CCI (14) is -100.73, which suggests HALO is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis